GLOBOCAN 2018 indicates a significant global increase in the numbers, incidence, and mortality rates, albeit significant differences in mortality amongst countries of different economic levels. 

Broadening eligibility critera for cancer clinical trials will give more patients the opportunity to contribute to scientific research.

Dr. Arjun Gupta reconsidered an order (and the evidence) for a neutropenic diet when it negatively affected his patient's quality of life.  

Dr. Edward S. Kim encourages you to register today and join the Research Community Forum in September for 2 days of learning and collaboration.

Clinical trials are the pathway to better treatments, better outcomes, and a future without cancer. We, as investigators, need to believe in them, and be willing to offer them to all patients who are eligible....